Journal of Pharmacological Reports
Open Access

The Impact of Pharmacotherapy on Infectious Diseases: Current Strategies and Challenges

Jenny Cruz^{* *}Correspondence: Jenny Cruz, Department of Clinical Pharmacology, University of Bern, Bern, Switzerland, Email:

Author info »

Description

Pharmacotherapy, the treatment of diseases and conditions with medications, is a fundamental aspect of modern medical practice. It involves the use of pharmaceutical agents to prevent, diagnose and treat illnesses. This article examines into the principles, types, applications and challenges of pharmacotherapy, highlighting its important role in healthcare [1].

Principles of pharmacotherapy

The principles of pharmacotherapy are essential to ensuring safe and effective treatment for patients. Here are some key principles.

Mechanism of action: Drugs exert their effects at the molecular, cellular, and system levels is fundamental. Drugs may act by binding to specific receptors, inhibiting enzymes, or modulating signaling pathways.

Pharmacokinetics: This encompasses the absorption, distribution, metabolism, and excretion (ADME) of drugs. Pharmacokinetics helps determine the appropriate dosage, route of administration and frequency of dosing to achieve optimal therapeutic levels [2].

Pharmacodynamics: This refers to the effects of drugs on the body and the relationship between drug concentration and effect. It includes the study of drug-receptor interactions, dose-response relationships and therapeutic and toxic effects.

Therapeutic window: The range of drug doses that produces therapeutic effects without causing significant adverse effects. Finding the balance within this window is critical for effective and safe treatment [3].

Types of pharmacotherapy

Pharmacotherapy can be categorized into different types based on its purpose and the way drugs are used in treatment.

Empirical therapy: Treatment initiated before a definitive diagnosis is made, based on clinical experience and probability.

For example, empirical antibiotic therapy is often used to treat suspected bacterial infections while awaiting culture results.

Rational therapy: Treatment based on a thorough understanding of the disease mechanism and the drug’s action. Rational therapy aims to select the most appropriate drug for a specific condition, minimizing adverse effects and maximizing therapeutic benefits [4].

Prophylactic therapy: Preventive treatment to avoid the occurrence of diseases or conditions. Vaccinations, anticoagulants to prevent thromboembolism and antimalarial drugs for travelers are examples of prophylactic therapy.

Symptomatic therapy: Treatment aimed at alleviating symptoms rather than curing the underlying disease. Pain relievers, antipyretics, and antiemetics fall into this category [5].

Applications of pharmacotherapy

Pharmacotherapy has a wide range of applications in the medical field, helping to treat, manage, or prevent various diseases and conditions.

Chronic disease management: Pharmacotherapy is essential for managing chronic diseases such as hypertension, diabetes and asthma. Long-term medication regimens help control symptoms, prevent complications and improve quality of life [6].

Infectious diseases: Antibiotics, antivirals, and antifungals are used to treat a wide range of infections. The choice of antimicrobial therapy is guided by the pathogen involved site of infection and patient factors.

Mental health disorders: Pharmacotherapy plays a important role in the treatment of mental health conditions such as depression, anxiety, schizophrenia and bipolar disorder. Antidepressants, antipsychotics and mood stabilizers are commonly used.

Cancer treatment: Chemotherapy, targeted therapies, and immunotherapies are integral components of cancer treatment. These therapies aim to kill or inhibit the growth of cancer cells while minimizing damage to normal tissues.

Acute conditions: Pharmacotherapy is often used to manage acute conditions such as pain, infections and allergic reactions. Rapid and effective treatment can prevent complications and improve patient outcomes [7].

Challenges in pharmacotherapy

Pharmacotherapy, while important for managing diseases and improving health, faces several challenges that can impact its effectiveness and safety.

Drug resistance: The development of resistance, particularly to antibiotics, poses a significant challenge. Strategies to combat resistance include the prudent use of antimicrobials, development of new drugs and implementation of infection control measures.

Adverse Drug Reactions (ADRs): ADRs can range from mild to life-threatening. Monitoring for and managing ADRs is important to ensure patient safety. Pharmacovigilance programs track and analyze ADRs to improve drug safety [8].

Polypharmacy: The use of multiple medications, often seen in elderly patients with multiple comorbidities, increases the risk of drug interactions and ADRs. Regular medication reviews and deprescribing when appropriate can mitigate these risks.

Patient adherence: Non-adherence to medication regimens can compromise treatment efficacy. Factors influencing adherence include the complexity of the regimen, side effects and patient education. Strategies to improve adherence include simplifying regimens addressing side effects, and patient education.

Personalized medicine: Individual variability in drug response due to genetic, environmental and lifestyle factors necessitates personalized approaches to pharmacotherapy. Advances in pharmacogenomics aim to tailor treatments based on genetic profiles to enhance efficacy and minimize adverse effects [9].

Future prospects

The future of pharmacotherapy holds exciting prospects, driven by advances in technology, science and personalized medicine.

Advancements in drug development: Ongoing research and technological innovations continue to drive the discovery and development of new drugs. Biotechnology, artificial intelligence and nanotechnology are expected to revolutionize pharmacotherapy.

Precision medicine: Precision medicine aims to customize healthcare, with medical decisions and treatments customized to individual patients. Pharmacogenomics, biomarker identification, and advanced diagnostic tools are key components of this approach [10].

Telemedicine and digital health: The integration of telemedicine and digital health tools can enhance patient monitoring, adherence, and management of pharmacotherapy. Remote consultations, mobile health applications and electronic health records are transforming healthcare delivery.

References

1. Babic JT, Sofjan A, Babin M. Significant publications on infectious diseases pharmacotherapy in 2015. Am J Health Syst Pharm. 2017;74(4):238-252.

   [Crossref] [Google Scholar]  [PubMed]

2. Borjan J, Gonzales-Luna AJ, Carlson TJ. Significant publications on infectious diseases pharmacotherapy in 2018. J Pharm Pract. 2019;32(5):546-557.

   [Crossref]  [Google Scholar][PubMed]

3. Bowers DR, Hunter AS, Jacobs DM. Significant publications on infectious diseases pharmacotherapy in 2012. Am J Health Syst Pharm. 2013;70(21):1930-1940.

   [Crossref][Google Scholar] [PubMed]

4. Chery, J. RNA therapeutics: RNAi and antisense mechanisms and clinical applications. Postdoc. J. 2016;4: 35-50.

   [Crossref] [Google Scholar]

5. McNally, EM Wyatt, E.J. Welcome to the splice age: Antisense oligonucleotide-mediated exon skipping gains wider applicability. J Clin Investig. 2016; 126:1236-1238.

   [Crossref] [Google Scholar]

6. Hua Y, Krainer, AR. Antisense-mediated exon inclusion. Methods Mol Biol. 2012; 867: 307–323.

   [Google Scholar]

7. Chan JH, Lim S, Wong WS. Antisense oligonucleotides: From design to therapeutic application. Clin Exp Pharmacol Physiol. 2006;33:533-540.

   [Crossref] [Google Scholar]

8. Watts JK. Corey DR. Silencing disease genes in the laboratory and the clinic. J Pathol. 2012; 226(2):365-79.

   [Crossref] [Google Scholar] [PubMed]

9. Nan Y, Zhang YJ. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds. Front Microbiol. 2018; 9:750.

   [Crossref]  [Google Scholar] [PubMed]

10. Oh SY, Ju Y, Park H. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol Cells. 2009; 28(4):341-345.

    [Crossref] [Google Scholar]  [PubMed]